EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic performance of serum oncostatin M and MMP-9 in differentiating disease activity in Crohn's disease and ulcerative colitis

Zahraa Nasser Ali, Hiba Resheed Behayaa, Ahmed Abdul-Hussein Gburi Alhilly

European Journal of Clinical and Experimental Medicine · 25.06.2026 · 24 (2)

DOI: 10.15584/ejcem.2026.2.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical and Experimental Medicine, online erschienen am 25.06.2026. Verfasst von Zahraa Nasser Ali und 2 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and aim. Inflammatory bowel disease (IBD) requires reliable noninvasive biomarkers for diagnosis and disease activity monitoring. Oncostatin M (OSM) and matrix metalloproteinase-9 (MMP-9) are implicated in intestinal inflammation and tissue remodeling, yet their combined diagnostic utility in IBD remains underexplored. The aim was to evaluate serum OSM and MMP-9 levels in Crohn's disease (CD) and ulcerative colitis (UC) patients compared to healthy controls, and to assess their correlation with disease activity and diagnostic performance. Material and methods. This cross-sectional study included 105 participants (35 CD, 35 UC, 35 controls). Serum OSM and MMP-9 were measured by ELISA. Disease activity was evaluated using CDAI and the Total Mayo Score. ROC curve analysis evaluated diagnostic accuracy. Results Both OSM and MMP-9 were significantly elevated in CD and UC compared to controls (p=0.016 and p=0.006, respectively), with progressive increases paralleling disease severity (p

Zitieren

APA

Ali, Z. N., Behayaa, H. R., & Alhilly, A. A. G. (2026). Diagnostic performance of serum oncostatin M and MMP-9 in differentiating disease activity in Crohn's disease and ulcerative colitis. European Journal of Clinical and Experimental Medicine, 24(2). https://doi.org/10.15584/ejcem.2026.2.16

Vancouver

Ali ZN, Behayaa HR, Alhilly AAG. Diagnostic performance of serum oncostatin M and MMP-9 in differentiating disease activity in Crohn's disease and ulcerative colitis. European Journal of Clinical and Experimental Medicine. 2026;24(2). doi:10.15584/ejcem.2026.2.16

BibTeX
@article{Ali2026,
  author = {Ali, Zahraa Nasser and Behayaa, Hiba Resheed and Alhilly, Ahmed Abdul-Hussein Gburi},
  title = {Diagnostic performance of serum oncostatin M and MMP-9 in differentiating disease activity in Crohn's disease and ulcerative colitis},
  journal = {European Journal of Clinical and Experimental Medicine},
  year = {2026},
  volume = {24},
  number = {2},
  doi = {10.15584/ejcem.2026.2.16}
}
Kostenlos starten →